These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 27651359)

  • 21. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungal microbiota dysbiosis in IBD.
    Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
    Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic.
    Ghannoum MA; McCormick TS; Retuerto M; Bebek G; Cousineau S; Hartman L; Barth C; Schrom K
    Curr Issues Mol Biol; 2021 Nov; 43(3):2135-2146. PubMed ID: 34940122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.
    Hetemäki I; Jian C; Laakso S; Mäkitie O; Pajari AM; de Vos WM; Arstila TP; Salonen A
    Front Immunol; 2021; 12():668219. PubMed ID: 34367134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses.
    Tyakht AV; Manolov AI; Kanygina AV; Ischenko DS; Kovarsky BA; Popenko AS; Pavlenko AV; Elizarova AV; Rakitina DV; Baikova JP; Ladygina VG; Kostryukova ES; Karpova IY; Semashko TA; Larin AK; Grigoryeva TV; Sinyagina MN; Malanin SY; Shcherbakov PL; Kharitonova AY; Khalif IL; Shapina MV; Maev IV; Andreev DN; Belousova EA; Buzunova YM; Alexeev DG; Govorun VM
    BMC Genomics; 2018 Dec; 19(1):968. PubMed ID: 30587114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease.
    Xing Y; Liu Y; Sha S; Zhang Y; Dou Y; Liu C; Xu M; Zhao L; Wang J; Wang Y; Ma X; Yan Q; Kong X
    J Med Virol; 2024 Jul; 96(7):e29781. PubMed ID: 38961767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Landscape in the gallbladder mycobiome and bacteriome of patients undergoing cholelithiasis with chronic cholecystitis.
    Hu J; Tang J; Zhang X; Yang K; Zhong A; Yang Q; Liu Y; Li Y; Zhang T
    Front Microbiol; 2023; 14():1131694. PubMed ID: 37032855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evidence for fungus in Crohn's disease pathogenesis.
    Miyoshi J; Sofia MA; Pierre JF
    Clin J Gastroenterol; 2018 Dec; 11(6):449-456. PubMed ID: 30027368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizations of the multi-kingdom gut microbiota in Chinese patients with gouty arthritis.
    Chen C; Zhang Y; Yao X; Yan Q; Li S; Zhong Q; Liu Z; Tang F; Liu C; Li H; Zhu D; Lan W; Ling Y; Lu D; Xu H; Ning Q; Wang Y; Jiang Z; Zhang Q; Gu G; Sun L; Wang N; Wang G; Zhang A; Ullah H; Sun W; Ma W
    BMC Microbiol; 2023 Nov; 23(1):363. PubMed ID: 38001408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection.
    Mukherjee PK; Chandra J; Retuerto M; Tatsuoka C; Ghannoum MA; McComsey GA
    PLoS One; 2018; 13(7):e0200285. PubMed ID: 29995962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
    Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
    Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
    Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
    J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.